Protagonist Therapeutics ... (PTGX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
37.76
0.88 (2.39%)
At close: Jan 23, 2025, 3:59 PM
37.80
0.11%
After-hours Jan 23, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
Cash & Equivalents | 186.73M | 125.74M | 123.67M | 117.36M | 33.01M | 82.23M | 106.03M | 21.08M | 4.05M | 9.32M |
Short-Term Investments | 154.89M | 111.61M | 203.24M | 188.45M | 100.01M | 46.62M | 37.97M | 56.52M | 7.87M | n/a |
Long-Term Investments | n/a | 225.00K | 225.00K | 2.00M | 450.00K | 450.00K | 11.46M | 10.15M | 30.00K | n/a |
Other Long-Term Assets | 225.00K | 5.72M | n/a | 450.00K | 450.00K | 450.00K | 450.00K | 34.00K | n/a | n/a |
Receivables | 10.33M | 52.00K | 1.57M | 2.43M | 6.75M | 6.51M | 3.22M | 2.24M | 715.00K | 523.00K |
Inventory | n/a | -94.00K | 8.50M | 3.98M | 4.79M | 2.14M | -8.75M | -7.65M | 1.26M | 10.00K |
Other Current Assets | 3.63M | 5.67M | 12.27M | 7.37M | 5.54M | 4.06M | 5.13M | 3.40M | 1.57M | 56.00K |
Total Current Assets | 355.58M | 237.35M | 340.74M | 315.61M | 145.31M | 137.50M | 150.95M | 83.24M | 14.21M | 9.91M |
Property-Plant & Equipment | 2.15M | 4.63M | 6.73M | 6.41M | 7.72M | 861.00K | 879.00K | 562.00K | 609.00K | 415.00K |
Goodwill & Intangibles | n/a | n/a | n/a | -1.04M | -450.00K | -450.00K | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.37M | 10.57M | 6.96M | 8.86M | 9.61M | 1.97M | 12.79M | 10.75M | 639.00K | 415.00K |
Total Assets | 357.95M | 247.93M | 347.69M | 324.47M | 154.92M | 139.47M | 163.73M | 93.99M | 14.85M | 10.33M |
Account Payables | 772.00K | 3.64M | 1.60M | 3.08M | 2.79M | 5.71M | 1.26M | 1.16M | 1.25M | 349.00K |
Deferred Revenue | n/a | 69.00K | 1.60M | 14.48M | 41.53M | 8.22M | 31.75M | n/a | n/a | n/a |
Short-Term Debt | 1.14M | 5.03M | 4.40M | 2.92M | 2.51M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 19.36M | 22.51M | 36.41M | 19.77M | 12.37M | 12.22M | 9.55M | 5.27M | 1.88M | 1.00M |
Total Current Liabilities | 21.27M | 31.18M | 44.02M | 40.24M | 35.41M | 26.16M | 42.55M | 6.43M | 3.13M | 1.35M |
Long-Term Debt | n/a | 1.14M | 3.66M | 4.50M | 15.76M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | -221.00K | n/a | n/a | 121.00K | n/a | 799.00K | 547.00K | n/a | 2.12M | 1.02M |
Total Long-Term Liabilities | n/a | 784.68M | 3.66M | 4.62M | 39.55M | 799.00K | 547.00K | n/a | 2.12M | 1.02M |
Total Liabilities | 21.27M | 784.68M | 47.67M | 44.86M | 74.95M | 26.96M | 43.10M | 6.43M | 5.25M | 2.37M |
Total Debt | 1.14M | 3.66M | 5.86M | 5.96M | 17.01M | n/a | n/a | n/a | n/a | n/a |
Common Stock | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -615.71M | -536.75M | -409.36M | -283.81M | -217.66M | -140.47M | -101.55M | -64.59M | -27.42M | -12.56M |
Comprehensive Income | -105.00K | -359.00K | -299.00K | 28.00K | -221.00K | -233.00K | -6.00K | -245.00K | -102.00K | -100.00K |
Shareholders Equity | 336.68M | -536.75M | -409.36M | -283.81M | -217.66M | -140.47M | -101.55M | -64.59M | 9.60M | 7.96M |
Total Investments | 154.89M | 111.61M | 203.24M | 190.45M | 100.01M | 46.62M | 49.43M | 66.67M | 7.87M | n/a |